Evidence map›Paper›PMID 32578948›Full record

ArticleInfluenza and other respiratory viruses2020

SARS-CoV-2 environmental contamination associated with persistently infected COVID-19 patients.

Hui Lei, Feng Ye, Xiaoqing Liu, Zhenting Huang, Shiman Ling, Zhanpeng Jiang, Jing Cheng, Xiaoqun Huang, Qiubao Wu, Shiguan Wu and 10 more

Abstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. SARS-CoV-2: a systematic review of indoor air sampling for virus detection.Environmental science and pollution research international · 2021
    Pooled it
  5. Pooled it
  6. Airborne transmission of SARS-CoV-2 via aerosols.Reviews in medical virology · 2021
    Pooled it
  7. [Is Disinfection of Public Surfaces useful for the Prevention of SARS-CoV-2 Infections?]Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) · 2021
    Pooled it
  8. Pooled it
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Transmission of SARS-CoV-2 in the workplace: Key findings from a rapid review of the literature.Aerosol science and technology : the journal of the American Association for Aerosol Research · 2023
    Article
  17. Article
  18. Article
  19. Measuring SARS-CoV-2 aerosolization in rooms of hospitalized patients.Laryngoscope investigative otolaryngology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Hui LeiGuangzhou Medical University, Guangzhou, China.
Feng YeState Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou, China.
Xiaoqing LiuState Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou, China.
Zhenting HuangGuangzhou Medical University, Guangzhou, China.
Shiman LingGuangzhou Medical University, Guangzhou, China.
Zhanpeng JiangGuangzhou Medical University, Guangzhou, China.
Jing ChengDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Xiaoqun HuangDepartment of Intensive Care, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Qiubao WuGuangzhou Medical University, Guangzhou, China.
Shiguan WuGuangzhou Medical University, Guangzhou, China.
Yanmin XieWHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
Cheng XiaoGuangzhou Medical University, Guangzhou, China.
Dan YeInfection Control, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Zifeng YangState Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou, China.
Yimin LiDepartment of Intensive Care, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Nancy H L LeungWHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0001-7314-840X
Benjamin J CowlingWHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-6297-7154
Jianxing HeDepartment of Thoracic Oncology and Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Sook-San WongGuangzhou Medical University, Guangzhou, China.ORCID 0000-0002-1290-191X
Mark ZaninGuangzhou Medical University, Guangzhou, China.ORCID 0000-0003-3158-1744

Funding

China Evergrande GroupGuangzhou Medical University
6 · The paper itself

Abstract

backgroundSevere COVID-19 patients typically test positive for SARS-CoV-2 RNA for extended periods of time, even after recovery from severe disease. Due to the timeframe involved, these patients may have developed humoral immunity to SARS-CoV-2 while still testing positive for viral RNA in swabs. Data are lacking on exposure risks in these situations. Here, we studied SARS-CoV-2 environmental contamination in an ICU and an isolation ward caring for such COVID-19 patients.

methodsWe collected air and surface samples in a hospital caring for critical and severe COVID-19 cases from common areas and areas proximal to patients.

resultsOf the 218 ICU samples, an air sample contained SARS-CoV-2 RNA. Of the 182 isolation ward samples, nine contained SARS-CoV-2 RNA. These were collected from a facemask, the floor, mobile phones, and the air in the patient room and bathroom. Serum antibodies against SARS-CoV-2 were detected in these patients at the beginning of the study.

conclusionsWhile there is a perception of increased risk in the ICU, our study demonstrates that isolation wards may pose greater risks to healthcare workers and exposure risks remain with clinically improved patients, weeks after their initial diagnoses. As these patients had serum antibodies, further studies may be warranted to study the utility of serum antibodies as a surrogate of viral clearance in allowing people to return to work. We recommend continued vigilance even with patients who appear to have recovered from COVID-19.

Indexed as

Environmental MicrobiologyAdultAged, 80 and overAntibodies, ViralBetacoronavirusCoronavirus InfectionsCOVID-19FemaleHumansIntensive Care UnitsMaleMiddle AgedPandemicsPatient IsolationPneumonia, ViralRNA, ViralAntibodies, ViralRNA, ViralcoronavirusCOVID-19intensive care unitSARS-CoV-2transmission

Identifiers

PMID32578948
PMCPMC7361718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.